LINDSEY MAKOVICKA: Open Payments
NPI 1881173797 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101 in 7 payments from 4 companies in 2025. Trend: 2023 $276 · 2024 $260 · 2025 $101
Food & beverage: $101
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Novo Nordisk Inc | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, AIRSUPRA, FARXIGA, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
